Ontology highlight
ABSTRACT: Background
Consensus on resectability criteria for colorectal cancer liver metastases (CRLM) is lacking, resulting in differences in therapeutic strategies. This study evaluated variability of resectability assessments and local treatment plans for patients with initially unresectable CRLM by the liver expert panel from the randomised phase III CAIRO5 study.Methods
The liver panel, comprising surgeons and radiologists, evaluated resectability by predefined criteria at baseline and 2-monthly thereafter. If surgeons judged CRLM as resectable, detailed local treatment plans were provided. The panel chair determined the conclusion of resectability status and local treatment advice, and forwarded it to local surgeons.Results
A total of 1149 panel evaluations of 496 patie
SUBMITTER: Bond MJG
PROVIDER: S-EPMC10409679 | biostudies-literature | 2023 Sep
REPOSITORIES: biostudies-literature